Eight Ohio biomedical companies have received a total of $8 million in grants from the state’s Third Frontier technology support program.
The grants, which awarded about $1 million to each firm, are aimed at accelerating the growth and development of Ohio’s burgeoning biomedical industry, which saw its number of jobs grow by 20 percent during the last decade.
The recipients are:
- Arteriocyte: The Cleveland-based stem cell company will further develop its NANEX technology, which uses stem cells to create (pdf) “universal-donor” red blood cells
- AtriCure: The publicly traded Cincinnati-area cardiac device maker will adapt its AtriClip device to be used in minimally invasive procedures
To read the full, original article click on this link: Eight Ohio biomedical companies get $8M in Third Frontier grants
Author: Brandon Glenn
